• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

局部晚期前列腺癌治疗后IgE多发性骨髓瘤的发生

The Development of IgE Multiple Myeloma Following Treatment for Locally Advanced Prostate Cancer.

作者信息

Fujita Motoki, Suzuki Issei, Mizuno Tomoya, Kobayashi Hiroyuki, Kambara Tsunehito

机构信息

Urology, Nasu Red Cross Hospital, Otawara, JPN.

Hematology, Nasu Red Cross Hospital, Otawara, JPN.

出版信息

Cureus. 2024 May 6;16(5):e59732. doi: 10.7759/cureus.59732. eCollection 2024 May.

DOI:10.7759/cureus.59732
PMID:38841024
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11152359/
Abstract

This case report documents the diagnosis of multiple myeloma (MM) in a 74-year-old man following treatment for locally advanced prostate cancer. It is important to include MM in the differential diagnosis when the patient presents with nonspecific symptoms such as back pain, anemia, and renal impairment in the absence of a prominent increase in prostate-specific antigen (PSA). The present case was diagnosed as IgE MM with a poor prognosis. Prompt diagnosis and intervention of MM is necessary to avoid complications, including renal impairment.

摘要

本病例报告记录了一名74岁男性在接受局部晚期前列腺癌治疗后多发性骨髓瘤（MM）的诊断情况。当患者出现背痛、贫血和肾功能损害等非特异性症状且前列腺特异性抗原（PSA）无显著升高时，在鉴别诊断中纳入MM很重要。本病例被诊断为预后不良的IgE型MM。对MM进行及时诊断和干预对于避免包括肾功能损害在内的并发症很有必要。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8788/11152359/75abb0f744bd/cureus-0016-00000059732-i02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8788/11152359/a45e82416fd0/cureus-0016-00000059732-i01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8788/11152359/75abb0f744bd/cureus-0016-00000059732-i02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8788/11152359/a45e82416fd0/cureus-0016-00000059732-i01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8788/11152359/75abb0f744bd/cureus-0016-00000059732-i02.jpg

相似文献

1
The Development of IgE Multiple Myeloma Following Treatment for Locally Advanced Prostate Cancer.局部晚期前列腺癌治疗后IgE多发性骨髓瘤的发生
Cureus. 2024 May 6;16(5):e59732. doi: 10.7759/cureus.59732. eCollection 2024 May.
2
[Multiple myeloma diagnosed during hormonal therapy for prostate cancer: report of two cases].[前列腺癌激素治疗期间诊断出的多发性骨髓瘤：两例报告]
Hinyokika Kiyo. 2012 May;58(5):243-7.
3
More advantages in detecting bone and soft tissue metastases from prostate cancer using F-PSMA PET/CT.使用F-PSMA PET/CT检测前列腺癌骨和软组织转移方面有更多优势。
Hell J Nucl Med. 2019 Jan-Apr;22(1):6-9. doi: 10.1967/s002449910952. Epub 2019 Mar 7.
4
5
Early-onset multiple myeloma: an illustrative case report.早发性多发性骨髓瘤：一例病例报告
J Manipulative Physiol Ther. 2007 Sep;30(7):543-9. doi: 10.1016/j.jmpt.2007.07.002.
6
A novel IgE antibody targeting the prostate-specific antigen as a potential prostate cancer therapy.一种新型 IgE 抗体靶向前列腺特异性抗原作为潜在的前列腺癌治疗方法。
BMC Cancer. 2013 Apr 17;13:195. doi: 10.1186/1471-2407-13-195.
7
Low IgE monoclonal gammopathy level in serum highlights 20-yr survival in a case of IgE multiple myeloma.血清中低IgE单克隆丙种球蛋白病水平提示1例IgE型多发性骨髓瘤患者的20年生存率。
Eur J Haematol. 2007 Apr;78(4):353-7. doi: 10.1111/j.1600-0609.2007.00825.x.
8
EAU guidelines on prostate cancer. Part II: Treatment of advanced, relapsing, and castration-resistant prostate cancer.EAU 前列腺癌指南。第二部分：晚期、复发性和去势抵抗性前列腺癌的治疗。
Eur Urol. 2014 Feb;65(2):467-79. doi: 10.1016/j.eururo.2013.11.002. Epub 2013 Nov 12.
9
Common complaints, difficult diagnosis: multiple myeloma.常见主诉，诊断困难：多发性骨髓瘤
J Am Acad Nurse Pract. 2006 May;18(5):190-4. doi: 10.1111/j.1745-7599.2006.00122.x.
10
Multivariate logistic regression analysis of the clinical factors influencing locally advanced prostate cancer.影响局部晚期前列腺癌的临床因素的多变量逻辑回归分析。
Transl Cancer Res. 2024 Feb 29;13(2):676-685. doi: 10.21037/tcr-23-1680. Epub 2024 Feb 26.

本文引用的文献

1
IgE multiple myeloma: detection and follow-up.IgE型多发性骨髓瘤：检测与随访
Adv Lab Med. 2021 Dec 30;3(1):79-90. doi: 10.1515/almed-2021-0087. eCollection 2022 Mar.
2
IgE type multiple myeloma exhibits hypermutated phenotype and tumor reactive T cells.IgE 型多发性骨髓瘤表现出高突变表型和肿瘤反应性 T 细胞。
J Immunother Cancer. 2022 Oct;10(10). doi: 10.1136/jitc-2022-005815.
3
Multiple Myeloma and Renal Failure: Mechanisms, Diagnosis, and Management.多发性骨髓瘤与肾衰竭：机制、诊断及管理
Cureus. 2022 Feb 25;14(2):e22585. doi: 10.7759/cureus.22585. eCollection 2022 Feb.
4
Biochemical Recurrence in Prostate Cancer and Temporal Association to Bone Metastasis.前列腺癌的生化复发及其与骨转移的时间关联。
Am J Case Rep. 2019 Oct 16;20:1521-1525. doi: 10.12659/AJCR.918569.
5
Clinical features of neuroendocrine prostate cancer.神经内分泌前列腺癌的临床特征。
Eur J Cancer. 2019 Nov;121:7-18. doi: 10.1016/j.ejca.2019.08.011. Epub 2019 Sep 13.
6
Recent Global Patterns in Prostate Cancer Incidence and Mortality Rates.近期全球前列腺癌发病率和死亡率模式。
Eur Urol. 2020 Jan;77(1):38-52. doi: 10.1016/j.eururo.2019.08.005. Epub 2019 Sep 5.
7
Synchronous Bone Metastasis From Multiple Myeloma and Prostate Adenocarcinoma as Initial Presentation of Coexistent Malignancies.多发性骨髓瘤和前列腺腺癌的同步骨转移作为并存恶性肿瘤的初始表现
Front Oncol. 2018 Apr 30;8:137. doi: 10.3389/fonc.2018.00137. eCollection 2018.
8
Early mortality after diagnosis of multiple myeloma: analysis of patients entered onto the United kingdom Medical Research Council trials between 1980 and 2002--Medical Research Council Adult Leukaemia Working Party.多发性骨髓瘤诊断后的早期死亡率：对1980年至2002年间进入英国医学研究委员会试验的患者的分析——医学研究委员会成人白血病工作组
J Clin Oncol. 2005 Dec 20;23(36):9219-26. doi: 10.1200/JCO.2005.03.2086. Epub 2005 Nov 7.
9
Is there an association between multiple myeloma and prostate cancer?多发性骨髓瘤与前列腺癌之间存在关联吗？
Med Hypotheses. 2004;63(2):226-31. doi: 10.1016/j.mehy.2003.10.029.
10
Recurrence of prostate adenocarcinoma presenting with multiple myeloma simulating skeletal metastases of prostate adenocarcinoma.前列腺腺癌复发伴多发性骨髓瘤，酷似前列腺腺癌骨转移。
Urology. 2002 Dec;60(6):1111. doi: 10.1016/s0090-4295(02)02074-5.